Prometheus Biosciences Inc. (RXDX) Fundamentals

Prometheus Biosciences Inc is a biotechnology company pioneering a precision medicine approach to the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment and diagnosis of...
SHARE INFORMATION
Market Cap$ 1,090,485,328
Shares Outstanding39,197,891
Float34,034,095
Percent Float86.83%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 3,129,000
Latest Fiscal EPS$ -3.65
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions230
Institutional Holdings Date2022-05-31
Institutional Bought Previous 3 Months4,127,383
Institutional Holdings Percent102.4%
Institutional Sold Previous 3 Months6,562,514
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months482,842
Insider Holdings Percent0.2
Insider Sold Previous 3 Months-
Insider Shares Owned92,833
TRADING INFO
52 Week High$ 51.96
52 Week Low$ 19.79
52 Week High Change$ 20.43
21 Day Moving Average$ 26.6157
21 Day Extended Moving Average$ 27.2051
50 Day Moving Average$ 27.3374
50 Day Extended Moving Average$ 28.7579
200 Day Moving Average$ 32.7315
200 Day Extended Moving Average$ 31.1366
10 Day Average Volume555,085
20 Day Average Volume498,702
30 Day Average Volume481,772
50 Day Average Volume504,728
Alpha0.033719
Beta2.6461
Standard Deviation0.200854
R20.349941
7 Day Price Change$ 1.02
7 Day Percent Change3.81%
21 Day Price Change$ -1.18
21 Day Percent Change-4.07%
30 Day Price Change$ -0.38
30 Day Percent Change-1.35%
Month to Date Price Change$ 1.76
Month to Date Percent Change6.75%
Quarter to Date Price Change$ -9.94
Quarter to Date Percent Change-26.32%
180 Day Price Change$ -9.76
180 Day Percent Change-25.97%
200 Day Price Change$ -5.32
200 Day Percent Change-16.05%
Year to Date Price Change$ -11.72
Year to Date Percent Change-29.64%

Prometheus Biosciences Inc. (RXDX) Key Ratios

PROFITABILITY
EBIT Margin-1,719.4%
EBITDA Margin-1,714.5%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 6,288,000
Revenue Per Share$ 0.1604
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book5.20
Total Debt To Equity0.10
Int Coverage-532.60
Current Ratio13.60
Leverage Ratio1.10
Quick Ratio13.20
Long Term Debt To Capital0.06
VALUATION MEASURES
PE Ratio-9.80
Enterprise Value$ 866,314,960
Price to Sales173.4232
Price to Free Cash-14.30
PE High Last 5 Years0.00
Price To Book5.20
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book5.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover3.80
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-37.77
Return on Equity-42.73
Return on Capital-40.86

Prometheus Biosciences Inc. (RXDX) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorBDO USA, LLP
CEOMark C. McKenna
Emplyoees72
Last AuditUE
CIK0001718852
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address9410 Carroll Park Drive
San Diego, CA 92121
Websitehttps://www.prometheusbiosciences.com
Facsimile-
Telephone+1 858 684-1300
Email-
Your Recent History
NASDAQ
RXDX
Prometheus..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220701 02:47:14